Brentuximab-vedotin maintenance following chemotherapy without irradiation for primary intracranial embryonal carcinoma in down syndrome.
about
Brentuximab-vedotin maintenance following chemotherapy without irradiation for primary intracranial embryonal carcinoma in down syndrome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Brentuximab-vedotin maintenanc ...... al carcinoma in down syndrome.
@en
Brentuximab-vedotin maintenanc ...... al carcinoma in down syndrome.
@nl
type
label
Brentuximab-vedotin maintenanc ...... al carcinoma in down syndrome.
@en
Brentuximab-vedotin maintenanc ...... al carcinoma in down syndrome.
@nl
prefLabel
Brentuximab-vedotin maintenanc ...... al carcinoma in down syndrome.
@en
Brentuximab-vedotin maintenanc ...... al carcinoma in down syndrome.
@nl
P2093
P2860
P1476
Brentuximab-vedotin maintenanc ...... al carcinoma in down syndrome.
@en
P2093
Daniel R Boué
Fahd Al-Sufiani
Jonathan L Finlay
Mohammad H Abu Arja
Suzanne E Conley
Violeta Salceda
P2860
P2888
P304
P356
10.1007/S00381-017-3690-9
P577
2017-12-13T00:00:00Z